Do fall-risk-increasing drugs have an impact on mortality in older hip fracture patients? A population-based cohort study

Annika Kragh Ekstam,1,2 Sölve Elmståhl1 1Division of Geriatric Medicine, Department of Health Sciences, Lund University, Skåne University Hospital, Malmö, 2Department of Medicine, Hässleholm Hospital, Hässleholm, Sweden Obje...

Full description

Bibliographic Details
Main Authors: Kragh Ekstam A, Elmståhl S
Format: Article
Language:English
Published: Dove Medical Press 2016-04-01
Series:Clinical Interventions in Aging
Subjects:
Online Access:https://www.dovepress.com/do-fall-risk-increasing-drugs-have-an-impact-on-mortality-in-older-hip-peer-reviewed-article-CIA
_version_ 1818421573189632000
author Kragh Ekstam A
Elmståhl S
author_facet Kragh Ekstam A
Elmståhl S
author_sort Kragh Ekstam A
collection DOAJ
description Annika Kragh Ekstam,1,2 Sölve Elmståhl1 1Division of Geriatric Medicine, Department of Health Sciences, Lund University, Skåne University Hospital, Malmö, 2Department of Medicine, Hässleholm Hospital, Hässleholm, Sweden Objective: The aim of this study was to assess the mortality in hip fracture patients with regard to use of fall-risk-increasing drugs (FRIDs), by comparing survival in exposed and nonexposed individuals. Design: This was a general population-based cohort study. Settings: Data on hip fracture patients were retrieved from three national databases. Participants: All hip fracture patients aged 60 years or older in a Swedish county in 2006 participated in this study. Measurements: We studied the mortality in hip fracture patients by comparing those exposed to FRIDs, combinations of FRIDs, and polypharmacy to nonexposed patients, adjusting for age and sex. For survival estimates in patients using four or more FRIDs, a Cox regression analysis was used, adjusting for age, sex, and use of any four or more drugs. Results: First-year all-cause mortality was 24.6% (N=503) in 2,043 hip fracture patients aged 60 years or older, including 170 males (33.8%) and 333 females (66.2%). Patients prescribed four or more FRIDs, five or more drugs (polypharmacy), psychotropic drugs, and cardiovascular drugs showed significantly increased first-year mortality. Exposure to four or more FRIDs (518 patients, 25.4%) was associated with an increased mortality at 30 days with odds ratios (ORs) 2.01 (95% confidence interval [CI] 1.44–2.79), 90 days with OR 1.56 (95% CI 1.19–2.04), 180 days with OR 1.54 (95% CI 1.20–1.97), and 365 days with OR 1.43 (95% CI 1.13–1.80). Cox regression analyses adjusted for age, sex, and use of any four or more drugs showed a significantly higher mortality in patients treated with four or more FRIDs at 90 days (P=0.015) and 180 days (P=0.012) compared to patients treated with three or less FRIDs. Conclusion: First-year all-cause mortality was significantly higher in older hip fracture patients exposed before the fracture to FRIDs, in particular to four or more FRIDs, polypharmacy, psychotropic, and cardiovascular drugs. Interventions aiming to optimize both safety and benefit of drug treatment for older people should include limiting the use of FRIDs. Keywords: mortality, hip fracture, fall-risk-increasing drugs, population based, older people
first_indexed 2024-12-14T13:12:30Z
format Article
id doaj.art-e0bab33498244fe6b2961368ba541206
institution Directory Open Access Journal
issn 1178-1998
language English
last_indexed 2024-12-14T13:12:30Z
publishDate 2016-04-01
publisher Dove Medical Press
record_format Article
series Clinical Interventions in Aging
spelling doaj.art-e0bab33498244fe6b2961368ba5412062022-12-21T23:00:09ZengDove Medical PressClinical Interventions in Aging1178-19982016-04-01Volume 1148949626693Do fall-risk-increasing drugs have an impact on mortality in older hip fracture patients? A population-based cohort studyKragh Ekstam AElmståhl SAnnika Kragh Ekstam,1,2 Sölve Elmståhl1 1Division of Geriatric Medicine, Department of Health Sciences, Lund University, Skåne University Hospital, Malmö, 2Department of Medicine, Hässleholm Hospital, Hässleholm, Sweden Objective: The aim of this study was to assess the mortality in hip fracture patients with regard to use of fall-risk-increasing drugs (FRIDs), by comparing survival in exposed and nonexposed individuals. Design: This was a general population-based cohort study. Settings: Data on hip fracture patients were retrieved from three national databases. Participants: All hip fracture patients aged 60 years or older in a Swedish county in 2006 participated in this study. Measurements: We studied the mortality in hip fracture patients by comparing those exposed to FRIDs, combinations of FRIDs, and polypharmacy to nonexposed patients, adjusting for age and sex. For survival estimates in patients using four or more FRIDs, a Cox regression analysis was used, adjusting for age, sex, and use of any four or more drugs. Results: First-year all-cause mortality was 24.6% (N=503) in 2,043 hip fracture patients aged 60 years or older, including 170 males (33.8%) and 333 females (66.2%). Patients prescribed four or more FRIDs, five or more drugs (polypharmacy), psychotropic drugs, and cardiovascular drugs showed significantly increased first-year mortality. Exposure to four or more FRIDs (518 patients, 25.4%) was associated with an increased mortality at 30 days with odds ratios (ORs) 2.01 (95% confidence interval [CI] 1.44–2.79), 90 days with OR 1.56 (95% CI 1.19–2.04), 180 days with OR 1.54 (95% CI 1.20–1.97), and 365 days with OR 1.43 (95% CI 1.13–1.80). Cox regression analyses adjusted for age, sex, and use of any four or more drugs showed a significantly higher mortality in patients treated with four or more FRIDs at 90 days (P=0.015) and 180 days (P=0.012) compared to patients treated with three or less FRIDs. Conclusion: First-year all-cause mortality was significantly higher in older hip fracture patients exposed before the fracture to FRIDs, in particular to four or more FRIDs, polypharmacy, psychotropic, and cardiovascular drugs. Interventions aiming to optimize both safety and benefit of drug treatment for older people should include limiting the use of FRIDs. Keywords: mortality, hip fracture, fall-risk-increasing drugs, population based, older peoplehttps://www.dovepress.com/do-fall-risk-increasing-drugs-have-an-impact-on-mortality-in-older-hip-peer-reviewed-article-CIAmortalityhip fracturefall-risk-increasing drugspopulation-basedolder people
spellingShingle Kragh Ekstam A
Elmståhl S
Do fall-risk-increasing drugs have an impact on mortality in older hip fracture patients? A population-based cohort study
Clinical Interventions in Aging
mortality
hip fracture
fall-risk-increasing drugs
population-based
older people
title Do fall-risk-increasing drugs have an impact on mortality in older hip fracture patients? A population-based cohort study
title_full Do fall-risk-increasing drugs have an impact on mortality in older hip fracture patients? A population-based cohort study
title_fullStr Do fall-risk-increasing drugs have an impact on mortality in older hip fracture patients? A population-based cohort study
title_full_unstemmed Do fall-risk-increasing drugs have an impact on mortality in older hip fracture patients? A population-based cohort study
title_short Do fall-risk-increasing drugs have an impact on mortality in older hip fracture patients? A population-based cohort study
title_sort do fall risk increasing drugs have an impact on mortality in older hip fracture patients a nbsp population based cohort study
topic mortality
hip fracture
fall-risk-increasing drugs
population-based
older people
url https://www.dovepress.com/do-fall-risk-increasing-drugs-have-an-impact-on-mortality-in-older-hip-peer-reviewed-article-CIA
work_keys_str_mv AT kraghekstama dofallriskincreasingdrugshaveanimpactonmortalityinolderhipfracturepatientsanbsppopulationbasedcohortstudy
AT elmstaringhls dofallriskincreasingdrugshaveanimpactonmortalityinolderhipfracturepatientsanbsppopulationbasedcohortstudy